← FDA Drug Approvals (Drugs@FDA)
JARDIANCE
NDA · New Drug Application · Sponsor: BOEHRINGER INGELHEIM · Approved 2014-08-01
Drug application
- FDA Application #
NDA204629- Application type
- New Drug Application
- Brand name
- JARDIANCE
- Generic name
- EMPAGLIFLOZIN
- Active ingredients
- EMPAGLIFLOZIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- BOEHRINGER INGELHEIM
- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- First approval
- 2014-08-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown